JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.28% |
| 2 | Healthcare | 12.84% |
| 3 | Financials | 10.61% |
| 4 | Consumer Discretionary | 7.72% |
| 5 | Industrials | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Telephone and Data Systems
TDS
$4.05B
| $2.29M | ﹤0.01% |
218,797
-122,498
| -36% | -$1.52M |
|
3302
National Healthcare
NHC
$3.5B
| $2.29M | ﹤0.01% |
38,480
-98,601
| -72% | -$5.98M |
|
|
ZYXI
3303
DELISTED
Zynex
ZYXI
| $2.29M | ﹤0.01% |
164,333
-14,606
| -8% | -$177K |
|
3304
Myers Industries
MYE
$1.24B
| $2.29M | ﹤0.01% |
102,803
+2,644
| +3% | +$54.9K |
|
3305
Cartesian Therapeutics
RNAC
$267M
| $2.29M | ﹤0.01% |
67,381
-200
| -0.3% | -$8.51K |
|
3306
Compass Minerals
CMP
$1.11B
| $2.28M | ﹤0.01% |
55,597
+6,473
| +13% | +$268K |
|
3307
CALL
DraftKings
DKNG
$13B
| $2.28M | ﹤0.01% |
200,000
-586,900
| -75% | -$8.17M |
|
3308
RXO
RXO
$3.88B
| $2.28M | ﹤0.01% |
+132,465
| New | +$2.35M |
|
|
ISEE
3309
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $2.28M | ﹤0.01% |
+106,300
| New | +$2.27M |
|
3310
Cerence
CRNC
$407M
| $2.27M | ﹤0.01% |
122,751
+210
| +0.2% | +$3.6K |
|
3311
CALL
Sunrun
RUN
$2.45B
| $2.27M | ﹤0.01% |
94,600
-7,500
| -7% | -$200K |
|
3312
Westamerica Bancorp
WABC
$1.38B
| $2.27M | ﹤0.01% |
38,506
-71,566
| -65% | -$4.21M |
|
|
MRSN
3313
DELISTED
Mersana Therapeutics
MRSN
| $2.27M | ﹤0.01% |
15,473
+13,068
| +543% | +$2.21M |
|
3314
Middlesex Water
MSEX
$1.11B
| $2.27M | ﹤0.01% |
28,801
-7,371
| -20% | -$640K |
|
|
MODN
3315
DELISTED
MODEL N, INC.
MODN
| $2.25M | ﹤0.01% |
55,569
+24,749
| +80% | +$932K |
|
|
TDCX
3316
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
| $2.25M | ﹤0.01% |
181,729
| – | – |
|
|
ROVR
3317
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $2.25M | ﹤0.01% |
613,185
+17,120
| +3% | +$73.4K |
|
3318
Dimensional US Small Cap ETF
DFAS
$16B
| $2.23M | ﹤0.01% |
+43,666
| New | +$2.25M |
|
3319
Fidelity Sustainable High Yield ETF
FSYD
$146M
| $2.22M | ﹤0.01% |
50,000
| – | – |
|
3320
Xperi
XPER
$329M
| $2.22M | ﹤0.01% |
+257,603
| New | +$2.95M |
|
3321
Mesa Laboratories
MLAB
$593M
| $2.21M | ﹤0.01% |
13,321
-176
| -1% | -$27.6K |
|
|
KALV
3322
DELISTED
KalVista Pharmaceuticals
KALV
| $2.21M | ﹤0.01% |
327,003
+190,809
| +140% | +$1.02M |
|
3323
Lucid Motors
LCID
$2.45B
| $2.21M | ﹤0.01% |
32,344
-6,610
| -17% | -$728K |
|
3324
Vera Therapeutics
VERA
$2.28B
| $2.21M | ﹤0.01% |
113,982
+38,652
| +51% | +$700K |
|
|
ARI
3325
Apollo Commercial Real Estate
ARI
$876M
| $2.2M | ﹤0.01% |
204,675
-29,980
| -13% | -$327K |
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,940 increased, 2,285 reduced and 594 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 594 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.